Optimal Surgical Timing and Outcome Prediction in Hemorrhagic Moyamoya Disease: A Retrospective Cohort Study
Open Access
- 9 May 2026
- journal article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (5) , e70917
Abstract
Objective: To develop and validate a prognostic nomogram incorporating optimal surgical timing thresholds for predicting long‐term outcomes in adult hemorrhagic moyamoya disease (MMD) patients undergoing encephaloduroarteriosynangiosis (EDAS). Methods: We conducted a retrospective cohort study of 256 consecutive adults with hemorrhagic MMD treated with EDAS (2013–2017) at a tertiary neurosurgical center. Using least absolute shrinkage and selection operator (LASSO) regression with 10‐fold cross‐validation, we identified key predictors for nomogram development. The model's performance was rigorously evaluated through discrimination (C‐index, AUC‐ROC), calibration, and decision curve analysis (DCA) in both training (70%) and validation (30%) cohorts. Results: Our hemorrhage‐specific nomogram incorporated five independent predictors: (1) age at initial hemorrhage, (2) surgical timing (optimal 3–6 month window post‐ictus), (3) preoperative functional status (modified Rankin Scale), (4) perioperative complications, and (5) recurrent hemorrhage. The model demonstrated excellent discrimination (C‐index: 0.889 training, 0.819 validation) and calibration. DCA confirmed superior clinical utility across 15%–80% probability thresholds compared to conventional approaches. Restricted cubic spline analysis validated the non‐linear relationship between surgical timing and outcomes. Conclusions: This study provides the first validated clinical decision tool for adult hemorrhagic MMD, establishing 3–6 months post‐hemorrhage as the optimal surgical window for EDAS. The nomogram's robust performance metrics and RCS‐validated temporal risk stratification offer neurosurgeons an evidence‐based approach to optimize revascularization timing and improve functional outcomes.Keywords
Funding Information
- National Natural Science Foundation of China (82171280)
- National Natural Science Foundation of China (82201451)
This publication has 51 references indexed in Scilit:
- High-risk age for rebleeding in patients with hemorrhagic moyamoya disease: long-term follow-up study.2003
- Long-term natural history of hemorrhagic type moyamoya disease in 42 patientsJournal of Neurosurgery, 2000
- Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya diseaseJournal of Neurosurgery, 2000
- Clinical Course, Surgical Management, and Long-Term Outcome of Moyamoya Patients With Rebleeding After an Episode of Intracerebral HemorrhageStroke, 1999
- Direct and indirect revascularization for Moyamoya disease surgical techniques and peri-operative complicationsClinical Neurology and Neurosurgery, 1997
- The efficacy of bypass surgery for the patients with hemorrhagic Moyamoya diseaseClinical Neurology and Neurosurgery, 1997
- Characteristics of intracranial aneurysms associated with moyamoya diseaseActa Neurochirurgica, 1996
- Angiographic demonstration of cerebral revascularization after encephalo-duro-arterio-synangiosis (EDAS) performed on pediatric moyamoya patients.1982
- A new surgical treatment of moyamoya disease in children: A preliminary reportSurgical Neurology, 1981
- Cerebrovascular "Moyamoya" DiseaseArchives of Neurology, 1969